Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 0.5 Contact Hour.

Acknowledgment of Support

This activity is supported by an educational grant from Incyte Corporation.

BURST CE™ Cholangiocarcinoma: Nursing Strategies for Improving Patient Outcomes with Novel and Emerging Therapies

Release Date: May 25, 2021
Expiration Date: May 25, 2022

Activity Overview

This brief online educational activity is designed to provide information on the emerging oral targeted therapies for patients with cholangiocarcinoma. This activity is presented in a multimedia format that includes an audio interview with Gabriel Schwartz, MSN, FNP-BC, AOCNP.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Incyte Corporation.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This activity is directed toward nurses and advanced practitioners involved in the treatment and management of cholangiocarcinoma.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to

  • Assess the biological rationale for current and emerging treatment strategies and implications for testing in cholangiocarcinoma management
  • Review current and emerging treatment approaches for the management of cholangiocarcinoma
  • Devise multidisciplinary strategies to ensure mitigation and timely management of toxicities associated with current and emerging therapies for cholangiocarcinoma
  • Utilize effective counseling strategies to educate regarding efficacy and safety of current and emerging therapies for patients with cholangiocarcinoma

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.


Gabriel Schwartz, MSN, FNP-BC, AOCNP
Gabriel Schwartz, MSN, FNP-BC, AOCNP
Nurse Practitioner
Department of GI Medical Oncology
Assistant Clinical Professor
Department of Family Healthcare Nursing
University of California, San Francisco Medical Center
San Francisco, CA

Disclosures: Consultant: Eisai, Exelixis; Speaker’s Bureau: Eisai; Editorial Support: Exelixis.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By